🌟 Introducing GenomeArc Horizon's Latest Innovation: SeqRx! 🌟 Dive into the future of personalized medicine with SeqRx, the newest module on the GenomeArc Horizon platform. SeqRx is embedded with genome interpretation to provide cutting-edge pharmacogenomic insights,

We are excited to announce GenomeArc’s clinical genomics webinar. On September 15th, we will have our very own Science Communication and Marketing Officer, Mariam Eldesouky, joining us. She will be discussing the application of GenomeArc Horizon for automated genomic tertiary

GenomeArc Horizon Version 2 integrates cutting-edge technologies to deliver unparalleled insights into rare disease and cancer genomics. Drawing from our experience analyzing thousands of genomes and exomes, we are proud to introduce the next generation of genomic solutions.

Happening Now: Clinical Genomics Webinar: m.youtube.com/watch?v=IlVVpN… #raredisorders #genomics

Application of GenomeArc Horizon on Rare Disorders Talk Link: youtube.com/watch?v=IlVVpN… #rarediseases #genomics #raredisease #clinicalgenomics

💫 We are excited to introduce Horizon Intelligence, our cutting-edge AI technology now powering the GenomeArc Horizon Platform. Let's plan for a demo request: lnkd.in/dQpCct4V or Email: [email protected] #AI #genomics #HorizonAI #clinicalAI #clinicalgenomics

Building intelligent technologies from multi-OMICs data for genetic diagnosis has been an incredible journey. We are excited to introduce the 'GenomeArc Horizon' a comprehensive multi-OMICs platform. Early access progra: lnkd.in/di6GeZH9 #rarediseases #cancer #genomics

GenomeArc Horizon transforming healthcare by providing life saving insights. For more info visit: genomearc.com/horizon #raredisease #cancer #Genomics #AI

🧬 It’s intriguing to find that the G6PD gene is recurrently mutated in over 3% of rare neurodevelopmental disorder (NDD) cases within a homogeneous cohort from Bangladesh, not observed in European NDD cohorts. Paper: gimjournal.org/article/S1098-… #rarediseases #Bangladesh

🧠 Review on Cancer ‘Omics: Artificial intelligence and omics in malignant gliomas by R Tambi et al. MBRU GenomeArc #Artificialintelligence #machinelearning #Gliomas 🔒ow.ly/K3gc50UgLZ1

Wishing you all a wonderful Christmas and a fantastic holiday season!🎄🎅 🇨🇦 #GenomeArc #Christmas #Holidays

☄️ Hmm, DeepSeek just made OpenAI’s revenue irrelevant. DeepSeek performs at level of OpenAi’s O1 (200$/month) with less GPUs. Most exciting part about DeepSeek open-source model is its ability to empower labs, scientists, and small businesses by fostering innovation.

Register now for an insightful talk on rapid genomics and multi-OMICs insights! Registration Link: lnkd.in/dJtnuFzJ #multiOMICs #webinar #genomics #variantanalytics #GenomeArc

Thrilled to share that our latest study, now published in Nature Medicine! Our study focuses on building population-specific pangenomes for underrepresented regions, with the goal of enhancing clinical genomics and advancing precision medicine. #pangenome nature.com/articles/s4159…

To report or not to report? The utilization of #VUS subclasses & the development of subclass-specific professional guidance are crucial for improving patient diagnosis and resource utilization bit.ly/44eexA7 #variantclassification #reclassification Heidi Rehm

✅ Cancer is a dynamic, evolving cellular system where genetically (somatic variants) distinct cellular subclones. Read more from Shaosen et al. paper on tumorigenesis: lnkd.in/dJtEazYy #CancerGenomics #Cancer #CancerResearch #PrecisionOncology #SomaticVariants

☄️ GenomeArc collaborating with Oxford Nanopore Technologies, in this webinar will highlight the power on AI in integrating multimodal data for tertiary genome analysis (for rare disease and cancer). Webinar Link: m.youtube.com/watch?v=sTxjJC… #cancer #rarediseases #cancer #nanopore

🔬GenomeArc Horizon Intelligence uses large language models (#LLMs) to create highly relevant gene panel from rare disease patients’ symptoms (from ERP) to search phenotype linked variants in genome 💡Read: genomearc.com/horizon #Genomics #RareDiseases #gene #genome #diagnosis